Results 61 to 70 of about 45,547 (280)
Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa +3 more
wiley +1 more source
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study. [PDF]
In a cohort of 2043 patients treated with immune checkpoint inhibitors (ICI), severe neurological immune‐related adverse events (n‐irAEs) occurred in 0.5% of cases. These events predominantly involved the peripheral nervous system (PNS) and showed variable onset.
Grisold A +10 more
europepmc +2 more sources
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
Objective The objective is to describe and compare demographic, clinical and serological characteristics of systemic sclerosis (SSc) patients according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet +33 more
wiley +1 more source
Background:: No evidenced link exists between myositis and incontinence, however myositis patients identify incontinence as an issue. This research was initiated in response to advocacy by consumers to investigate this topic.
G. Simkovics +5 more
doaj +1 more source
Background Interstitial lung disease (ILD) is a prognostic indicator of poor outcome in myositis. Although the pathogenesis of myositis-associated ILD is not well understood, neutrophils are thought to play a pivotal role.
Noriho Sakamoto +15 more
doaj +1 more source
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019
Background The medical care of patients with myositis is a great challenge in clinical practice. This is due to the rarity of these disease, the complexity of diagnosis and management as well as the lack of systematic analyses.
Marc Pawlitzki +10 more
doaj +1 more source
ZusammenfassungEntzündliche Muskelerkrankungen stellen eine wichtige Gruppe der seltenen neuromuskulären Erkrankungen dar. Die Diagnose der Myositiden hat einen besonderen Stellenwert, da sie im Gegensatz zu vielen anderen hereditären neuromuskulären ...
W. Müller-Felber +7 more
core +1 more source
Unraveling a Diagnostic Enigma: A TECPR2 Case Solved Through Multi‐Omic Genomics
ABSTRACT TECPR2 is a key regulator of autophagy, encoded by the TECPR2 gene. Pathogenic variants in this gene have been linked to a rare hereditary sensory and autonomic neuropathy with intellectual disability (HSAN9). We report a teenage female with a syndromic intellectual disability disorder associated with neuromuscular abnormalities.
Teresa Zhao +122 more
wiley +1 more source
A Case Report on Parvovirus B19 Associated Myositis
Introduction. Whilst there are reports of viral myopathies affecting children and the immunocompromised, infective myositis is a relatively rare inflammatory myopathy in adults.
Nathan D. Oliver +2 more
doaj +1 more source
Inclusion body myositis is a rare idiopathic inflammatory myopathy that produces extreme muscle weakness. Blood flow restricted resistance training has been shown to improve muscle strength and muscle hypertrophy in inclusion body myositis.
M.T. Neves Jr. +7 more
core +1 more source

